ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma

por Iseda, Norifumi, Itoh, Shinji, Yoshizumi, Tomoharu, Yugawa, Kyohei, Morinaga, Akinari, Tomiyama, Takahiro, Toshima, Takeo, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki
Publicado 2020

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection

por Itoh, Shinji, Tomiyama, Takahiro, Morinaga, Akinari, Kurihara, Takeshi, Nagao, Yoshihiro, Toshima, Takeo, Morita, Kazutoyo, Harada, Noboru, Mori, Masaki, Yoshizumi, Tomoharu
Publicado 2022

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma

por Yugawa, Kyohei, Itoh, Shinji, Yoshizumi, Tomoharu, Iseda, Norifumi, Tomiyama, Takahiro, Morinaga, Akinari, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki
Publicado 2020

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients

por Toshida, Katsuya, Itoh, Shinji, Tomiyama, Takahiro, Morinaga, Akinari, Kosai, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Nagao, Yoshihiro, Morita, Kazutoyo, Harada, Noboru, Yoshizumi, Tomoharu
Publicado 2022

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature

por Iseda, Norifumi, Yoshizumi, Tomoharu, Toshima, Takeo, Morinaga, Akinari, Tomiyama, Takahiro, Takahashi, Junichi, Motomura, Takashi, Mano, Yohei, Itoh, Shinji, Harada, Noboru, Ikegami, Toru, Soejima, Yuji
Publicado 2018

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report

por Shimagaki, Tomonari, Itoh, Shinji, Toshida, Katsuya, Tomiyama, Takahiro, Morinaga, Akinari, Kosai, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Nagao, Yoshihiro, Morita, Kazutoyo, Harada, Noboru, Yoshizumi, Tomoharu
Publicado 2022

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report

por Tomiyama, Takahiro, Motomura, Takashi, Iseda, Norifumi, Morinaga, Akinari, Shimagaki, Tomonari, Kurihara, Takeshi, Wang, Huanlin, Toshima, Takeo, Nagao, Yoshihiro, Itoh, Shinji, Harada, Noboru, Yoshizumi, Tomoharu, Mori, Masaki
Publicado 2021

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma

por Toshida, Katsuya, Itoh, Shinji, Harada, Noboru, Morinaga, Akinari, Yugawa, Kyohei, Tomiyama, Takahiro, Kosai‐Fujimoto, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Nagao, Yoshihiro, Morita, Kazutoyo, Oda, Yoshinao, Yoshizumi, Tomoharu
Publicado 2022

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma

por Itoh, Shinji, Yoshizumi, Tomoharu, Tomiyama, Takahiro, Iseda, Norifumi, Morinaga, Akinari, Shimagaki, Tomonari, Wang, Huanlin, Kurihara, Takeshi, Nagao, Yoshihiro, Toshima, Takeo, Harada, Noboru, Nishie, Akihiro, Ishigami, Kousei, Mori, Masaki
Publicado 2021

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma

por Iseda, Norifumi, Itoh, Shinji, Toshida, Katsuya, Tomiyama, Takahiro, Morinaga, Akinari, Shimokawa, Masahiro, Shimagaki, Tomonari, Wang, Huanlin, Kurihara, Takeshi, Toshima, Takeo, Nagao, Yoshihiro, Harada, Noboru, Yoshizumi, Tomoharu, Mori, Masaki
Publicado 2022

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report

por Nagao, Yoshihiro, Toshida, Katsuya, Morinaga, Akinari, Tomiyama, Takahiro, Kosai, Yukiko, Shimagaki, Tomonari, Tomino, Takahiro, Wang, Huanlin, Kurihara, Takeshi, Toshima, Takeo, Morita, Kazutoyo, Itoh, Shinji, Harada, Noboru, Yoshizumi, Tomoharu
Publicado 2022

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study

por Tomiyama, Takahiro, Harada, Noboru, Toshima, Takeo, Nakayama, Yuki, Toshida, Katsuya, Morinaga, Akinari, Kosai-Fujimoto, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Takeishi, Kazuki, Nagao, Yoshihiro, Morita, Kazutoyo, Itoh, Shinji, Yoshizumi, Tomoharu
Publicado 2022

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma

por Tomiyama, Takahiro, Itoh, Shinji, Iseda, Norifumi, Toshida, Katuya, Morinaga, Akinari, Yugawa, Kyohei, Fujimoto, Yukiko Kosai, Tomino, Takahiro, Kurihara, Takeshi, Nagao, Yoshihiro, Morita, Kazutoyo, Harada, Noboru, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki, Yoshizumi, Tomoharu
Publicado 2022

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status

por Iseda, Norifumi, Itoh, Shinji, Yoshizumi, Tomoharu, Tomiyama, Takahiro, Morinaga, Akinari, Yugawa, Kyohei, Shimokawa, Masahiro, Shimagaki, Tomonari, Wang, Huanlin, Kurihara, Takeshi, Kitamura, Yoshiyuki, Nagao, Yoshihiro, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Baba, Shingo, Ishigami, Kousei, Oda, Yoshinao, Mori, Masaki
Publicado 2021

DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples

por Izumi, Takuma, Morioka, Yuhei, Urayama, Syun-ichi, Motooka, Daisuke, Tamura, Tomokazu, Kawagishi, Takahiro, Kanai, Yuta, Kobayashi, Takeshi, Ono, Chikako, Morinaga, Akinari, Tomiyama, Takahiro, Iseda, Norifumi, Kosai, Yukiko, Inokuchi, Shoichi, Nakamura, Shota, Tanaka, Tomohisa, Moriishi, Kohji, Kariwa, Hiroaki, Yoshizumi, Tomoharu, Mori, Masaki, Matsuura, Yoshiharu, Fukuhara, Takasuke
Publicado 2021